Great Point Partners LLC Uro Gen Pharma Ltd. Transaction History
Great Point Partners LLC
- $377 Million
- Q2 2024
A detailed history of Great Point Partners LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Great Point Partners LLC holds 2,906,259 shares of URGN stock, worth $36.9 Million. This represents 12.93% of its overall portfolio holdings.
Number of Shares
2,906,259
Previous 2,620,545
10.9%
Holding current value
$36.9 Million
Previous $39.3 Million
24.06%
% of portfolio
12.93%
Previous 9.62%
Shares
6 transactions
Others Institutions Holding URGN
# of Institutions
119Shares Held
39.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.56MShares$45.2 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$41.9 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$39.2 Million0.78% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$31.1 Million0.11% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$29.2 Million0.27% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $289M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...